Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001579547 | SCV001823624 | likely benign | not provided | 2020-06-02 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001579547 | SCV004669412 | likely benign | not provided | 2024-03-16 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004039460 | SCV005037538 | likely benign | Cardiovascular phenotype | 2023-09-22 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Genome Diagnostics Laboratory, |
RCV001579547 | SCV001807634 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001579547 | SCV001969712 | likely benign | not provided | no assertion criteria provided | clinical testing |